Bristol-Myers Squibb Co (BMY)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

430 E. 29TH STREET NEW YORK, NY 10016

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other healthcare-related products. The Company has three segments: Pharmaceuticals, Nutritionals and ConvaTec. The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business. The other two segments Nutritionals and ConvaTec comprise the Company's Health Care Group. The Nutritionals segment consists of Mead Johnson Nutritionals (Mead Johnson), primarily an infant formula and children's nutritionals business. The ConvaTec segment consists of the ostomy, wound and skin care business.

Data based on most recent fiscal year report
Market Cap102.736 Billion Shares Outstanding1.637 Billion Avg Volume12.73 Million
1-Yr BETA vs S&P TR Current Ratio1.55 Quick Ratio1.43
View SEC Filings from BMY instead.
Q3 2019 All Institutions Hedge Funds 1
To trade BMY now:
Filers who had this stock in their top 10: 46 14 (1.46%)
13F Filers holding this stock: 1711 116 (12.12%)
Aggregate 13F shares on 09/30/2019: 1.343 Billion 103.354 Million
Aggregate 13F shares on 06/30/2019: 1.312 Billion 107.983 Million
Percent change: 2.34% -4.29%
Funds creating new positions: 129 14
Funds Adding to an existing position: 686 39
Funds closing out their position: 87 24
Funds reducing their position: 672 52
Heat Map Ranking for 09/30/2019 57
Heat Map Ranking for 06/30/2019 57
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BMY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

40 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

592 total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WILLIAMS R SANDERS

  • Director
5,413 2019-11-06 0

SCHMUKLER LOUIS S PRES., GLOBAL MFG. & SUPPLY

  • Officer
31,963 2019-11-05 2

ELICKER JOHN E SVP, PUBLIC AFFAIRS & IR

  • Officer
74,471 2019-11-05 2

GORDON MURDO EVP GLOBAL COMMERCIAL OPS

  • Officer
34,024 2019-11-02 0

GLIMCHER LAURIE H M.D.

  • Director
3,600 2019-11-01 0

DANIELS BRIAN

  • Director
0 2019-10-24 0

SATO VICKI L

  • Director
1,669,110 2019-10-10 1

LEVIN JEREMY M CEO

  • Officer
  • Director
  • 10% Owner
5,237,106 2019-10-08 0

CELENTANO JOHN E

  • Director
0 2019-10-02 0

BIONDI PAUL SVP, HEAD OF STRATEGY & BD

  • Officer
6,214 2019-10-02 2

GROBSTEIN MICHAEL

  • Director
0 2019-09-30 5

STORCH GERALD L

  • Director
0 2019-09-30 5

LACY ALAN J

  • Director
0 2019-09-30 5

PALIWAL DINESH C

  • Director
0 2019-09-30 5

ARDUINI PETER J

  • Director
0 2019-09-30 5

SAMUELS THEODORE R. II

  • Director
0 2019-09-30 6

EMMENS MATTHEW

  • Director
0 2019-09-30 5

BERTOLINI ROBERT J

  • Director
0 2019-09-30 6

VOUSDEN KAREN H

  • Director
0 2019-09-30 5

JOHANSSON LEIF

  • Director
0 2019-09-05 0

SANTIAGO KAREN MURPHY CONTROLLER

  • Officer
3,487 2019-09-01 4

HIRAWAT SAMIT CHIEF MEDICAL OFFR., DRUG DEV.

  • Officer
0 2019-07-01 2

EID JOSEPH SVPHEAD GLOBAL MEDICAL AFFAIRS

  • Officer
2,170 2019-06-12 1

POWELL ANN SVP, GLOBAL HUMAN RESOURCES

  • Officer
31,826 2019-06-10 2

ANDREOTTI LAMBERTO

  • Director
14,219 2019-06-03 0

SIGAL ELLIOT

  • Director
14,214 2019-05-30 0

CUSS FRANCIS M

  • Director
0 2019-05-23 0

BANCROFT CHARLES A

  • Director
8,114 2019-05-13 4

CAFORIO GIOVANNI CHAIRMAN AND CEO

  • Officer
  • Director
368,066 2019-05-05 2

LYNCH THOMAS J. JR. EVP & CHIEF SCIENTIFIC OFFICER

  • Officer
22,223 2019-04-03 2

LEUNG SANDRA EVP, GENERAL COUNSEL

  • Officer
552,282 2019-03-10 2

VON AUTENRIED PAUL SVP, ENTERP. SERVICES & CIO

  • Officer
134,727 2019-03-10 1

DUBOW ADAM CHIEF COMPLIANCE & ETHICS OFFI

  • Officer
18,390 2019-03-10 1

BOERNER CHRISTOPHER S. EVP, CHIEF COMMERCIAL OFFICER

  • Officer
9,386 2019-03-10 2

BASELGA JOSE

  • Director
No longer subject to file 2018-09-30 0

STORCH GERALD L

STORCH GERALD L

  • Director
0 2018-09-30 5

ROBINSON JAMES D III

  • Director
  • 10% Owner
8,710,679 2018-05-29 0

HOOPER ANTHONY C EVP, GLOBAL COMMERCIAL OPS.

  • Officer
215,147 2018-05-03 0

HELLER FRANCES K

  • Director
47,961 2017-10-13 0

CALDARELLA JOSEPH C SVP & CONTROLLER

  • Officer
48,076 2017-09-06 0

NIELSEN ANNE CHIEF COMPLIANCE & ETHICS OFF

  • Officer
37,974 2017-09-03 0

CORNELIUS JAMES M

  • Director
No longer subject to file 2017-06-15 0

WEST TOGO D JR

  • Director
0 2017-04-06 0

BLIN EMMANUEL SVP, CHIEF STRATEGY OFFICER

  • Officer
20,138 2017-03-10 0

CAMPBELL LEWIS B

  • Director
2,110 2016-03-08 0

MOED SAMUEL J SVP, STRAT PLAN & ANALYSIS

  • Officer
31,615 2015-03-13 0

CAZALA BEATRICE J EVP COMMERCIAL OPERATIONS

  • Officer
177,118 2013-05-31 0

FREEH LOUIS J

  • Director
0 2013-02-01 0

CARLO DE NOTARISTEFANI PRES TECH OPS & SUPP FNCTNS

  • Officer
8,432 2011-06-14 0

ZITO ROBERT T SVP & CHIEF COMM OFFICER

  • Officer
35,469 2010-03-06 0

MCBRIDE ANTHONY A SVP HUMAN RESOURCES

  • Officer
34,292 2010-03-06 0

HUET JEAN-MARC EVP & CFO

  • Officer
25,000 2009-04-30 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

SCHMUKLER LOUIS S - Officer PRES., GLOBAL MFG. & SUPPLY

2019-11-05 S 25,000 $56.56 d 31,963 31,963.47 direct

ELICKER JOHN E - Officer SVP, PUBLIC AFFAIRS & IR

2019-11-05 S 15,000 $56.66 d 74,471 74,470.58 direct

BIONDI PAUL - Officer SVP, HEAD OF STRATEGY & BD

2019-10-02 M 592 d 1,184 6,214.00 direct

BIONDI PAUL - Officer SVP, HEAD OF STRATEGY & BD

2019-10-02 F 203 $49.21 d 6,214 6,214.00 direct

BIONDI PAUL - Officer SVP, HEAD OF STRATEGY & BD

2019-10-02 M 592 a 6,417 6,214.00 direct

BERTOLINI ROBERT J - Director

2019-09-30 A 653 $50.71 a 16,237 0.00 direct

SAMUELS THEODORE R. II - Director

2019-09-30 A 604 $50.71 a 15,055 0.00 direct

LACY ALAN J - Director

2019-09-30 A 604 $50.71 a 73,030 0.00 direct

VOUSDEN KAREN H - Director

2019-09-30 A 764 $50.71 a 9,868 0.00 direct

PALIWAL DINESH C - Director

2019-09-30 A 727 $50.71 a 29,123 0.00 direct

EMMENS MATTHEW - Director

2019-09-30 A 715 $50.71 a 16,423 0.00 direct

ARDUINI PETER J - Director

2019-09-30 A 715 $50.71 a 21,313 0.00 direct

STORCH GERALD L - Director

2019-09-30 A 641 $50.71 a 51,753 0.00 direct

GROBSTEIN MICHAEL - Director

2019-09-30 A 345 $50.71 a 82,349 0.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments